COLORADO STATE UNIVERSITY
In vivo assessment and optimization of phage PK/PD for the treatment of pulmonary Mycobacterium abscessus infection
In vivo assessment and optimization of phage PK/PD for the treatment of pulmonary Mycobacterium abscessus infection is a funding opportunity from COLORADO STATE UNIVERSITY, up to 782871, closing January 31, 2029.
Jan 31, 2029
(915d left)Overview
Nontuberculous mycobacteria (NTM) are environmental bacteria that cause serious pulmonary infections in people with underlying lung diseases. One of the most common NTMs associated with pulmonary disease is Mycobacterium abscessus (Mabs). Mabs is highly drug resistant, and it is the most difficult NTM to treat. The…